Idexx Laboratories, Inc.
IDEXX Laboratories Amends Credit Agreement
Summary
On November 12, 2025, IDEXX Laboratories, Inc. amended its fourth amended and restated credit agreement. The amendment adjusts the maturity dates, assigns new obligations, and modifies interest rates based on the company's leverage ratio. The amended credit agreement includes a $1.0 billion unsecured revolving credit facility, a $250 million unsecured term loan, and the option to incur additional commitments up to $250 million.
Profitelligence Alerts
Get alerts for IDXX
Be first to know when Idexx Laboratories, Inc. files with the SEC.
Filing Categories
Advertisement
About Idexx Laboratories, Inc.
Idexx Laboratories, Inc. is a prominent player in the health technology industry, specializing in veterinary diagnostics, software, and water microbiology testing. The company develops and markets products and services that enhance animal health and well-being, offering a wide range of diagnostic tests for companion animals, livestock, and poultry. It is notably recognized for providing innovative diagnostic services including in-house analyzers and rapid assays, which facilitate quick and accurate diagnostic results for veterinarians. Besides its veterinary focus, Idexx Laboratories also provides water testing solutions aimed at ensuring the safety and quality of water supplies by identifying microbial contaminants. The firm’s advanced diagnostic technologies significantly impact the animal health sector by delivering efficient, reliable diagnostics that enable proactive animal care. Idexx stands out as a key player in enhancing laboratory efficiency through its cloud-based practice management software, improving day-to-day operations for veterinary practices worldwide. Headquartered in Westbrook, Maine, Idexx Laboratories' mission and products underscore its vital role in advancing global animal health and environmental testing solutions, making it a significant entity in the health technology market.
Official SEC Documents
Advertisement